Delivery Order SPE2DB20D3303-SPE2DB25FA3KH
- Not listed
- The Defense Logistics Agency awarded a $17,340.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This non-set-aside competitive award was issued on September 25, 2025, with an ultimate completion date of September 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $18,423.65 by the Defense Logistics Agency on September 8, 2025, for the supply of Orencia ClickJect 125 mg/mL. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 9, 2025. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,594.04 by the Defense Logistics Agency (DLA) for the supply of Orencia ClickJect 125 mg/mL on May 29, 2025. This competitively awarded, firm fixed-price contract with an ultimate completion date of May 30, 2025 represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award carries no set-aside designation,...
- The Defense Logistics Agency awarded a $20,892.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on September 8, 2025, with completion scheduled for September 9, 2025. This non-set-aside contract represents a small-value transaction for a specialty pharmaceutical product delivered to the place of performance in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $17,548.12 delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other inflammatory conditions. The contract, awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $14,837.03 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-set-aside award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $11,053.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used primarily for rheumatoid arthritis treatment. The contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competitive, non-set-aside delivery order executed through the company's existing DLA contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $23,618.84 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat autoimmune conditions. This firm fixed-price delivery order, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a non-competitive, non-set-aside award. The place of performance is listed as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location....
- The Defense Logistics Agency awarded a delivery order valued at $7,561.38 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product. The contract, designated as a firm fixed price delivery order with no set-aside, was awarded on May 6, 2025, with an ultimate completion date of May 7, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $22,728.76 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml, a pharmaceutical product used in treating autoimmune conditions. This non-competitive, firm fixed-price delivery order was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3KHDelivery Order
The Defense Logistics Agency awarded a $7,188.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on September 8, 2025, with completion targeted for September 9, 2025. This non-competitive delivery order will be fulfilled at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) relationship with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's DLA contract vehicle enables supply of a comprehensive range of pharmaceutical products and medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This specific delivery order for Orencia, a biologic medication used in the treatment of rheumatoid arthritis and other autoimmune conditions, reflects AmerisourceBergen's ongoing role as a primary supplier of specialty pharmaceuticals to the federal military healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 9/8/25 |